Two-stage public-private partnership proposal for R&D on neglected diseases

Brigitte Granville and Eshref Trushin

No 36, Working Papers from Queen Mary, University of London, School of Business and Management, Centre for Globalisation Research

Abstract: We propose a 2-stage procurement model of public-private partnership to provide better incentives for R&D on neglected diseases. The model combines advance market commitment, subsidized clinical trials, and rewards based on therapeutical contributions of new drugs through a prize screening mechanism. The model is primarily intended to facilitate small firms’ R&D by providing cash flow, rewarding quality of new drugs, and sharing risks and costs of new drugs development, while limiting moral hazards. The model’s advantages include reduction of overpayments, better disclosure of information, provision of production licences, and direct targeting of better quality drugs.

Keywords: neglected diseases; prize screening; pharmaceutical R&D (search for similar items in EconPapers)
JEL-codes: D82 H41 I12 I18 (search for similar items in EconPapers)
Date: 2010-10
New Economics Papers: this item is included in nep-cta and nep-ino
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://cgr.sbm.qmul.ac.uk/CGRWP36.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cgs:wpaper:36

Access Statistics for this paper

More papers in Working Papers from Queen Mary, University of London, School of Business and Management, Centre for Globalisation Research Contact information at EDIRC.
Bibliographic data for series maintained by Pedro S. Martins ().